Form 4: Novanta Inc. CFO Executes Stock Option and Sells Shares Under 10b5-1 Plan
SEC Form 4 Filing
Novanta Inc.'s Chief Financial Officer, Robert Buckley, exercised stock options and sold shares on December 2, 2024, under a pre-established 10b5-1 trading plan.
Summary
- Robert Buckley, the Chief Financial Officer of Novanta Inc., engaged in transactions involving the company's stock on December 2, 2024.
- He exercised stock options to acquire 2,041 shares at a price of $14.13 per share.
- Following the exercise of options, Mr. Buckley sold a total of 2,041 shares in multiple transactions at prices ranging from $165.36 to $170.07.
- These sales were executed under a pre-established Rule 10b5-1 trading plan adopted on March 12, 2024.
- The weighted average sale prices for the transactions were $165.87, $166.84, $167.95, $169.02 and $169.92.
- After these transactions, Mr. Buckley directly owns 120,419 shares of Novanta Inc.
Sentiment
Score: 5
Explanation: The document reflects routine insider trading activity under a pre-established plan, which is neither particularly positive nor negative.
Risks
- The sales by the CFO could be perceived negatively by the market, although they were conducted under a pre-established trading plan.
- The market may react to the insider selling activity, potentially impacting the stock price.
Industry Context
This is a routine filing related to insider trading activity and is common for executives who have stock options and pre-planned trading strategies. It does not indicate any specific trend in the industry.
Comparison to Industry Standards
- The use of a 10b5-1 trading plan is a common practice among executives at publicly traded companies to avoid accusations of insider trading.
- The reported transactions are typical for executives exercising stock options and selling shares for personal financial management.
- The price range of the sales is within the normal trading range of the stock.
Stakeholder Impact
- The transactions may have a minor impact on the stock price, but are unlikely to significantly affect other stakeholders.
Key Dates
| Date | Description |
|---|---|
| 03/30/2017 | First vesting date of the stock options. |
| 03/30/2018 | Second vesting date of the stock options. |
| 03/30/2019 | Third vesting date of the stock options. |
| 03/12/2024 | Date the 10b5-1 trading plan was adopted. |
| 12/02/2024 | Date of the stock option exercise and share sales. |
| 12/04/2024 | Date the Form 4 was signed. |
Keywords
Novanta Inc, Robert Buckley, insider trading, stock options, Rule 10b5-1, CFO, stock sales
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.